Evidence map›Paper›PMID 40775392›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Surgical management of rare lesions in the parapharyngeal space.

Hongbo Xu, Weiwei Wang, Xiujuan Kou, Nyall R London, Xiaohong Chen, Lifeng Li

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hongbo XuDepartment of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 1stDongjiaominxiang, Dongcheng District, Beijing, 100730, China.
Weiwei WangDepartment of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 1stDongjiaominxiang, Dongcheng District, Beijing, 100730, China.
Xiujuan KouDepartment of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 1stDongjiaominxiang, Dongcheng District, Beijing, 100730, China.
Nyall R LondonDepartment of Otolaryngology-Head & Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Xiaohong ChenDepartment of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 1stDongjiaominxiang, Dongcheng District, Beijing, 100730, China.
Lifeng LiDepartment of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 1stDongjiaominxiang, Dongcheng District, Beijing, 100730, China. entllf@hotmail.com.ORCID http://orcid.org/0000-0002-0114-7608

Funding

Digestive Medical Coordinated Development Center of Beijing Hospitals Authority PX2024008
6 · The paper itself

Abstract

backgroundLesions in the parapharyngeal space (PPS) are diverse. Management strategies for commonly seen PPS lesions (i.e., pleomorphic adenoma and schwannoma) have been widely accepted while less well defined for more rare PPS tumors. The purpose of this study was to retrospectively review rare entities of the PPS, and to evaluate the role of minimally invasive surgical approaches for management of rare entities in this complex region.

methodsFrom Jan 1, 2010 to Dec 31, 2021, 328 patients who harbored PPS tumors were included and retrospectively reviewed. Those patients with a common PPS tumor (pleomorphic adenoma and schwannoma) were excluded. Fifty-one patients with rare PPS entities were included (42 patients with benign lesions and 9 patients with malignancies). Demographics, pathological outcomes, and treatment strategies for patients with rare entities were evaluated and retrospectively reviewed.

resultsA minimally invasive surgical approach (i.e., transoral endoscopic approach, or as a combined approach) was adopted in 52.4% of cases for extirpation of benign cases in the PPS. For malignancies in the PPS, the transoral endoscopic approach was applied in 66.7% of malignant cases such as metastatic lymph node dissection or biopsy. Moreover, the traditional approach (i.e., transcervical transparotid approach with or without mandibulotomy) accounted for 47.6% and 33.3% for management of complex benign and malignancies in the PPS, respectively.

conclusionRare entities arising in the PPS are diverse. An endoscopic transoral approach can be appropriately utilized in more than half of rare entities including both the benign tumors and malignancies in the PPS.

Indexed as

Adenoma, PleomorphicParapharyngeal SpacePharyngeal NeoplasmsRare DiseasesAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMinimally Invasive Surgical ProceduresOtorhinolaryngologic Surgical ProceduresRetrospective StudiesYoung AdultCombinedParapharyngeal spaceRareSurgeryTreatment strategyTumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.